NEW YORK–(BUSINESS WIRE)–PWNHealth (PWN), a national clinician network and leading provider of diagnostic testing solutions and telehealth services, today announced an expansion of its COVID-19 testing initiative. Since April 2020, PWN’s platform has supported more than 10 million COVID-19 polymerase chain reaction (PCR), antibody and antigen tests. With support for at home, drive-thru and point of care options, PWN is playing a pivotal role in the nation’s efforts to scale testing by providing the technical, clinical and operational infrastructure needed to seamlessly stand-up programs where they are needed most, and is tripling its capacity over the coming months.
From the onset of the pandemic, PWN has bolstered national COVID-19 testing efforts through clinical oversight, lab connectivity, results management and care delivery for a broad array of government, pharmacy and lab partners across the U.S., Puerto Rico and the District of Columbia.
PWN connects individuals with licensed clinicians and healthcare professionals to review results and recommend additional actions as needed. To date, more than 450K Americans with a positive or indeterminate result have received clinical support and guidance from PWN to ensure they know what to do next. This end-to-end service commitment has resulted in a patient Net Promoter Score of 79, demonstrating a superior level of satisfaction from participants receiving PWN-backed testing. Additionally, PWN reports testing data back to county and state Departments of Health. This connectivity ensures optimal data integrity and turnaround times for contact tracing, a key step to stop the spread of the virus.
“While access to testing is a critical component of the country’s COVID-19 mitigation effort, testing is only as effective as the patient comprehension and response that follows. Our emphasis on informed patients cannot be overstated, as it is the education and clinical consultation that ensures testing programs achieve the best possible outcomes for participants,” said Sanjay Pingle, CEO of PWNHealth.
In September 2020, PWNHealth launched its COVID-19 testing dashboard to highlight key testing trends among local and national demographics. To date, PWN-supported PCR and antigen tests have returned a 5.4 percent positive rate.
For more information about PWNHealth and its complete diagnostic testing solutions portfolio, visit pwnhealth.com.
PWNHealth is a national clinician network working to improve early detection and prevention of disease using advanced diagnostics and telehealth. Our solutions provide the clinical, legal, and technological framework to facilitate population-scale testing across key healthcare markets in all 50 states and Puerto Rico. PWN is supporting over 45 national COVID-19 testing programs and have managed more than 10 million COVID-19 tests through our platform. We believe that empowering people with convenient access to clinically actionable testing has the power to change lives, improve outcomes, and create a healthier world. PWN is backed by leading growth equity firms Spectrum Equity and the Blue Venture Fund (BVF). For more information, visit www.pwnhealth.com. Follow us on Twitter, LinkedIn and Medium.